Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an adapted antibiotic regimen for Hurley stage 2 hidradenitis suppurativa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapted Antibiotherapy

Snippet

Sponsor: Institut Pasteur | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: RECRUITING